School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
J Med Chem. 2023 Jun 8;66(11):7086-7100. doi: 10.1021/acs.jmedchem.3c00366. Epub 2023 May 25.
Cocaine is one of the oldest and most widely used illicit drugs in the world and is responsible for major worldwide medical and social problems. Drug addiction is a disease state where the body relies on a substance for normal functioning and develops a physical dependence leading to compulsive and repetitive use despite negative consequences to the user's health, mental state, or social life. The primary driver for the development of anti-cocaine vaccines has been the failure to develop effective pharmacological treatments to combat cocaine dependence. Despite several decades of research, no approved pharmacological treatments for cocaine dependence are available to assist addicts to overcome cocaine withdrawal or to prevent drug relapse. This Perspective highlights the challenges associated with anti-cocaine vaccines, including the current state of anti-cocaine vaccines and catalytic antibody research to aid in the fight against cocaine addiction.
可卡因是世界上最古老、使用最广泛的非法药物之一,是造成全球重大医学和社会问题的根源。药物成瘾是一种身体依赖某种物质以维持正常功能的疾病状态,导致患者不顾对健康、精神状态或社交生活的负面影响而强迫性地、重复地使用该物质。开发抗可卡因疫苗的主要驱动力是未能开发出有效的药物治疗方法来对抗可卡因依赖。尽管进行了几十年的研究,但目前还没有批准用于治疗可卡因依赖的药物治疗方法,无法帮助成瘾者戒除可卡因或预防药物复发。本观点重点介绍了抗可卡因疫苗所面临的挑战,包括抗可卡因疫苗和催化抗体研究的现状,以帮助对抗可卡因成瘾。